CBN Oil 12000mg – Cannabinol

Technical Specifications

  • Active Cannabinoid: Cannabinol (CBN)
  • Total Potency: 12,000 mg CBN
  • Bottle Volume: 50 ml (1.7 fl oz)
  • Concentration: 240 mg CBN per 1 ml
  • Extract Type: Full Spectrum
  • THC Content: Zero THC (THC-free)
  • Extraction Method: Supercritical CO₂ extraction
  • Carrier Oil: Medium Chain Triglycerides (MCT oil)
  • Additional Ingredients: Hemp Sativa L. Aerial Parts
  • Alcohol: Alcohol-free
  • Manufacturing: EU-based clean room, GMP-compliant facility
  • Delivery Format: Tincture (oral drops)
  • Packaging: Glass dropper bottle
  • Origin: Colorado, USA (hemp source)
  • Compliance: TGA-compliant for Australian regulations

$330.00

Description

Cannabinol (CBN) oil at 12,000 mg represents a high-potency, THC-free formulation designed for experienced cannabinoid users seeking concentrated doses of cannabinol without the need for large serving sizes. CBN forms naturally through the degradation of tetrahydrocannabinol (THC) as it oxidises over time due to exposure to light, heat, and air. This product delivers 12,000 mg of CBN in a 50 ml bottle, providing a concentration of 240 mg per millilitre—four times the potency of standard 3000 mg formulations. The increased concentration allows for precise micro-dosing and flexibility in adjusting cannabinoid intake based on individual needs.

The extraction process employs supercritical CO₂ technology, a solvent-free method that isolates cannabinoids from hemp biomass under precise temperature and pressure parameters. This technique avoids the use of alcohol or hydrocarbon solvents, which can leave residues or alter the chemical profile of the final product. Supercritical CO₂ extraction is particularly effective at removing plant lipids, waxes, and chlorophyll, resulting in a cleaner oil that integrates smoothly into daily use. The absence of alcohol in the final formulation ensures that users sensitive to ethanol or those avoiding alcohol for personal or religious reasons can use this product confidently.

This CBN oil is classified as full spectrum, meaning it retains a broad range of naturally occurring cannabinoids, terpenes, and flavonoids present in the hemp plant. While CBN is the primary cannabinoid, the oil may contain trace amounts of CBD, CBG, CBC, and other minor compounds depending on the source material and batch. The synergy between these compounds is often referred to as the entourage effect, a phenomenon where cannabinoids and terpenes work together to enhance bioavailability and interaction with the body’s endocannabinoid system. Despite being full spectrum, this product maintains zero detectable THC through a targeted refinement process that isolates and removes THC molecules while preserving the integrity of other cannabinoids and terpenes.

High-Potency Manufacturing and Quality Control

The carrier oil used in this formulation is MCT (medium-chain triglycerides), derived from fractionated coconut oil. MCT oil is selected for its rapid absorption rate and neutral flavour profile, which minimises the earthy, hempy taste that some users find unpalatable in raw cannabis extracts. When administered sublingually, the oil is held under the tongue for 30 to 60 seconds, allowing cannabinoids to be absorbed directly through the mucous membranes into the bloodstream. This method bypasses hepatic first-pass metabolism, leading to faster onset and higher bioavailability compared to oral ingestion. For high-potency formulations, sublingual administration is particularly effective, as it maximises cannabinoid absorption while minimising waste.

Manufacturing takes place in an EU-based clean room facility that adheres to Good Manufacturing Practice (GMP) standards. Clean room environments are designed to minimise contamination by controlling airborne particles, temperature, humidity, and microbial activity. GMP compliance ensures that each batch is produced under consistent conditions, with rigorous quality control measures applied at every stage of production. This includes testing for cannabinoid potency, heavy metals, pesticides, residual solvents, and microbial contaminants. Users should verify batch-specific Certificates of Analysis (COA) through the manufacturer’s website to confirm the absence of THC and the presence of declared cannabinoid levels.

CBN interacts with the endocannabinoid system, which is present in all mammals. However, it is critical to emphasise that CBN oil is not intended to diagnose, treat, cure, or prevent any disease. Users should approach cannabinoid supplementation with appropriate caution and consult healthcare professionals before use, especially if taking prescription medications or managing chronic health conditions.

Dosage, Storage, and Usage for High-Potency Formulations

Dosage protocols for high-potency CBN oil require careful attention due to the concentrated cannabinoid content. Users new to CBN should start with a very low dose—such as 0.1 to 0.25 ml (24 to 60 mg CBN)—and adjust incrementally based on personal response. Experienced users transitioning from lower-potency formulations (e.g., 3000 mg) may begin with 0.25 to 0.5 ml (60 to 120 mg CBN) once or twice daily. Consistency in timing and dosage helps maintain stable cannabinoid levels in the system. Users should avoid exceeding recommended serving sizes without professional guidance, as higher doses do not necessarily correlate with improved outcomes.

Storage recommendations include keeping the bottle in a cool, dark environment away from direct sunlight, heat sources, and moisture. Glass dropper bottles provide protection against light degradation, but prolonged exposure to heat can still compromise cannabinoid potency. High-potency formulations may be more sensitive to temperature fluctuations, so storage in a stable environment is essential. Once opened, the product should be used within six months to ensure freshness and efficacy. In warmer climates (such as much of Australia), refrigeration may extend shelf life, but the oil should be allowed to return to room temperature before use to ensure accurate dosing consistency.

This 12,000 mg CBN oil represents a premium, high-tier strength option within the cannabinol market, suitable for experienced users or those requiring higher doses for consistent cannabinoid intake. The full spectrum profile, combined with zero THC content and supercritical CO₂ extraction, positions this product as a versatile option for consumers prioritising high-potency cannabinoid diversity without psychoactive risk.

Aurum Australis brings this premium high-potency CBN oil to Australian consumers as part of a carefully selected cannabinoid portfolio. Whether you’re transitioning from lower-strength formulations or seeking advanced cannabinoid supplementation, our range of full spectrum, broad spectrum, and THC-free products ensures you find the right cannabinoid profile and strength for your needs.

Frequently Asked Questions (FAQ)

What makes 12,000 mg CBN oil different from 3000 mg formulations?

The primary difference is cannabinoid concentration. A 12,000 mg CBN oil contains 240 mg CBN per millilitre, while a 3000 mg formulation contains 60 mg per millilitre—four times the potency. This higher concentration allows for smaller serving sizes, greater dosing flexibility, and improved cost-effectiveness for users requiring larger daily doses. High-potency formulations are designed for experienced cannabinoid users who have already established a baseline response with lower-strength products (3000 mg or 6000 mg). Beginners should start with lower-potency options to assess individual tolerance, metabolism, and response to CBN before transitioning to high-potency formulations.

Is 12,000 mg CBN oil completely THC-free, and why does this matter?

Yes, this 12,000 mg CBN oil is formulated to contain zero detectable THC, despite being classified as full spectrum. This is achieved through a targeted refinement process that isolates and removes THC molecules while preserving other cannabinoids, terpenes, and flavonoids. The absence of THC is particularly important for high-potency formulations, as users taking larger doses would otherwise accumulate more THC over time, increasing the risk of psychoactive effects or positive drug test results. Batch-specific Certificates of Analysis (COA) confirm the absence of THC through third-party laboratory testing, ensuring compliance with Australian TGA regulations and international hemp standards.

How should I transition from lower-potency CBN oil to this high-strength formulation?

Transitioning to high-potency CBN oil requires careful dose adjustment to avoid cannabinoid saturation. If you’re currently using a 3000 mg formulation at 0.5 ml per dose (30 mg CBN), start with 0.125 ml of the 12,000 mg formulation (30 mg CBN) to maintain the same cannabinoid intake. Monitor your body’s response for several days before adjusting the dose incrementally. High-potency formulations offer greater precision in micro-dosing, allowing you to fine-tune your cannabinoid intake more accurately. Always consult with a healthcare professional before transitioning to higher-strength products, particularly if you’re taking prescription medications or managing chronic health conditions.